Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...

The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...

GAITHERSBURG, MD (updated) — A Food and Drug Administration (FDA) advisory committee narrowly voted in favor of a novel device that measures pulmonary-artery (PA) pressures in patients with heart ...

St. Vincent's Medical Center is now helping doctors and patients with heart failure (HF) manage their health with a tiny, implantable wireless monitoring sensor. The CardioMEMS HF System is the first ...

Heart disease that progresses into heart failure leaves people in a dangerous state in which acute decompensation events can happen at any time. Being able to monitor such patients day and night ...

(RTTNews) - Abbott (ABT) said data from an investigator-sponsored European trial found managing indicated heart failure patients with CardioMEMS HF System resulted in a significant improvement in ...

SPRINGFIELD, Mass. (WWLP) – Pioneer Valley Cardiology Associates at Mercy Medical Center has introduced the CardioMEMS Heart Failure Monitoring Program, a cutting-edge initiative to improve heart ...

Atlanta, Georgia-based health device maker CardioMEMS received FDA clearance for its CardioMEMS HF System, which monitors pulmonary artery pressure, but for patients who have experienced New York ...

Abbott Laboratories, Inc. ABT presented new data from an investigator-sponsored European study — MONITOR-HF. The study revealed that Abbott's CardioMEMS HF System led to a significant improvement in ...

The U.K.’s National Institute for Health and Care Excellence (NICE) has recommended the use of Abbott Laboratories’ Cardiomems HF system, giving people living with heart failure an option to monitor ...

In the first randomized clinical trial of remote pulmonary artery pressure–guided monitoring and management of chronic heart failure (HF) in Europe, the intervention "substantially" improved quality ...

Atlanta – May 7, 2010. CardioMEMS, Inc., a medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today ...